首页|Nogo-B敲除NAFLD小鼠的肠道微生物群和血清代谢组学变化研究

Nogo-B敲除NAFLD小鼠的肠道微生物群和血清代谢组学变化研究

扫码查看
背景 非酒精性脂肪性肝病(nonalcoholic fatty liver disease,NAFLD)是目前全球范围内最常见的慢性肝病,Nogo-B作为其潜在治疗靶点,需确定是否会对肠道微生物群及代谢途径产生影响.目的 探讨Nogo-B敲除对NAFLD的保护作用,明确Nogo-B敲除对NAFLD小鼠肠道微生物群和血清代谢产物的影响.方法 12只 8周龄野生型小鼠随机分为野生正常饮食组(WT-NCD组)和野生高脂饮食组(WT-HFD组).12只 8周龄Nogo-B敲除(Nogo-B-/-)小鼠随机分为Nogo-B敲除正常饮食组(Nogo-B-/--NCD组)和Nogo-B敲除高脂饮食组(Nogo-B-/--HFD组).WT-HFD组和Nogo-B-/--HFD组小鼠通过喂食 12周 60 kal%的高脂饮食构建NAFLD小鼠模型,WT-NCD组和Nogo-B-/--NCD组小鼠则同时喂食正常饮食.4组小鼠均测量体质量;酶联免疫吸附测定检测 4组小鼠的肝三酰甘油(triglyceride,TG)和总胆固醇(total cholesterol,TC)水平;苏木精-伊红染色评估 4组小鼠的肝病理学特征;对WT-HFD组和Nogo-B-/--HFD组小鼠进行肠道微生物群和血清代谢物检测.结果 12周造模结束后,与WT-NCD组小鼠相比,WT-HFD组小鼠的体质量及肝组织中TC、TG水平升高(P<0.01);与Nogo-B-/--NCD组小鼠相比,Nogo-B-/--HFD组小鼠的体质量及肝组织中TC、TG水平升高(P<0.01);而当Nogo-B敲除后,与WT-HFD组小鼠相比,Nogo-B-/--HFD组小鼠的体质量及肝组织中TC、TG水平下降(P<0.01);肠道微生物组学显示Nogo-B敲除后丁酸球菌科成为其肠道微生物中的优势物种;血清代谢组学显示两组间(WT-HFD组、Nogo-B-/--HFD组)筛选到差异代谢物 159种(上调 79,下调 80种),极其显著富集(P<0.001)的代谢通路为柠檬酸循环/三羧酸循环(tricarboxylic acid cycle,TCA cycle)等,主要富集到的代谢物为柠檬酸、琥珀酸、异柠檬酸盐和苹果酸.结论 Nogo-B敲除后的NAFLD小鼠肝脂质积累情况减轻,肠道有益微生物群增加,一定程度上改善代谢紊乱.Nogo-B可能是NAFLD治疗的潜在靶点.
Gut microbiota and serum metabolomic changes in Nogo-B knockout NAFLD mice
Background Nonalcoholic fatty liver disease(NAFLD)is the most common chronic liver disease worldwide.As a potential therapeutic target,Nogo-B is needed to determine whether it has an impact on the intestinal microbiome and metabolic pathways.Objective To explore the protective effect of Nogo-B knockdown on NAFLD and clarify the effects of Nogo-B knockdown on gut microbiota and serum metabolites in NAFLD mice.Methods Twelve 8-week-old wild type(WT)mice were randomly divided into WT-NCD group and WT-HFD group.Twelve 8-week-old Nogo-B knockout(Nogo-B-/-)mice were randomly divided into Nogo-B-/--NCD group and Nogo-B-/--HFD group.Mice in the WT-HFD and Nogo-B-/--HFD groups were fed with 60 kal%high-fat diet(HFD)for 12 weeks to construct the NAFLD mouse model,while mice in the WT-NCD and Nogo-B-/--NCD groups were fed with normal chow diet(NCD)for the same amount of time.Body weight was measured in all four groups.The hepatic triglyceride(TG)and total cholesterol(TC)levels were measured by enzyme-linked immunosorbent assay(ELISA);hematoxylin-eosin(HE)staining was used to evaluate the hepatic pathological features of mice in the four groups;and the gut microbiota and sera metabolites were examined in mice of the WT-HFD and the Nogo-B-/--HFD groups.Results At the end of 12-week modeling,the body weight and TC and TG levels in liver tissues of mice in the WT-HFD group were elevated compared with mice in the WT-NCD group(P<0.01);and the body weight and TC and TG levels in liver tissues of mice in the Nogo-B-/--HFD group were also elevated compared with those of mice in the Nogo-B-/--NCD group(P<0.01);whereas when the Nogo-B was knockout,the body weight and TC and TG levels in liver tissues of mice in the Nogo-B-/--HFD group decreased compared with those in the WT-HFD group(P<0.01);intestinal microbiomics showed that Butyricicoccaceae became the dominant species in the gut microbes of Nogo-B knockdown NAFLD mice;serum metabolomics showed that 159 different metabolites were screened between the two groups(WT-HFD group,Nogo-B-/--HFD group),79 were up-regulated and 80 were down-regulated,and the metabolic pathways that were extremely significantly enriched(P<0.001)were the citrate cycle/tricarboxylic acid cycle(TCA cycle),etc.,and the major enriched metabolites were citric acid,succinic acid,isocitrate and malic acid.Conclusion NAFLD mice with Nogo-B knockout show reduced hepatic lipid accumulation,increased beneficial intestinal microbiota,and improved metabolic disorders to some extent.Nogo-B may be a potential target for NAFLD therapy.

nonalcoholic fatty liver diseasehigh-fat dietNogo-Bgut microbiotametabolomics

董旭、郑从洋、柏兆方、高利利

展开 >

解放军医学院,北京 100853

解放军总医院第二医学中心消化内科,北京 100853

解放军总医院第五医学中心肝病医学部研究所,北京 100039

非酒精性脂肪性肝病 高脂饮食 Nogo-B 肠道微生物群 代谢组学

2024

解放军医学院学报
解放军总医院-军医进修学院

解放军医学院学报

CSTPCD
影响因子:0.811
ISSN:2095-5227
年,卷(期):2024.45(6)